Search / 150 results found

from
to
  • Updated

THE WOODLANDS, Texas, July 27, 2021 /PRNewswire/ -- Excelerate Energy (Excelerate), a U.S.-based LNG company, today announced a joint donation with fellow members of the U.S.-Bangladesh Business Council (the Council) to provide medical supplies to aid in Bangladesh's fight against COVID-19. The Council partnered with nonprofit organization Project C.U.R.E., the world's largest distributor of donated medical equipment and supplies to resource-limited communities across the globe.

  • Updated

HOUSTON and SINGAPORE, July 26, 2021 /PRNewswire/ -- Hummingbird Bioscience, an innovative clinical-stage biotech company focused on developing precision therapies against hard-to-drug targets, today announced that internationally renowned scientist and medical oncologist, Dr. Thomas J Lynch, Jr, MD, has been appointed to its Board as a Non-Executive Director, effective immediately.

  • Updated

AUSTIN, Texas, July 22, 2021 /PRNewswire/ -- The leader of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently led a clinical study to evaluate the world's first data-driven artificial intelligence (AI) platform for cardiac electrophysiology (EP) procedures. Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI, conducted the first-in-human trial in Europe.

  • Updated

AUSTIN, Texas, July 22, 2021 /CNW/ -- The leader of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently led a clinical study to evaluate the world's first data-driven artificial intelligence (AI) platform for cardiac electrophysiology (EP) procedures. Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI, conducted the first-in-human trial in Europe.                                                                                                            

  • Updated

AUSTIN, Texas, July 22, 2021 /PRNewswire/ -- The leader of the Texas Cardiac Arrhythmia Institute (TCAI) at St. David's Medical Center recently led a clinical study to evaluate the world's first data-driven artificial intelligence (AI) platform for cardiac electrophysiology (EP) procedures. Andrea Natale, M.D., F.H.R.S., F.A.C.C., F.E.S.C., cardiac electrophysiologist and executive medical director of TCAI, conducted the first-in-human trial in Europe.                                                                                                            

  • Updated

DALLAS, July 22, 2021 /CNW/ -- Cosm, a global experiential media and immersive technology company, celebrates the grand opening of the 420,000-square foot Shanghai Astronomy Museum.  The expertise of Cosm companies Evans & Sutherland (E&S) and Spitz, Inc. is showcased inside the museum's world-class planetarium and an adjacent exhibit, which feature two NanoSeam domes and the industry-leading Digistar 7 planetarium software.  Cosm, through E&S and Spitz, Inc. was awarded the prestigious and highly competitive contract two years ago due to the companies' unparalleled industry reputation, experience, and technology.

  • Updated

DALLAS, July 22, 2021 /PRNewswire/ -- Cosm, a global experiential media and immersive technology company, celebrates the grand opening of the 420,000-square foot Shanghai Astronomy Museum.  The expertise of Cosm companies Evans & Sutherland (E&S) and Spitz, Inc. is showcased inside the museum's world-class planetarium and an adjacent exhibit, which feature two NanoSeam domes and the industry-leading Digistar 7 planetarium software.  Cosm, through E&S and Spitz, Inc. was awarded the prestigious and highly competitive contract two years ago due to the companies' unparalleled industry reputation, experience, and technology.